News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,509 Results
Type
Article (43386)
Company Profile (356)
Press Release (692752)
Multimedia
Podcasts (86)
Webinars (17)
Section
Business (208178)
Career Advice (2075)
Deals (35951)
Drug Delivery (115)
Drug Development (82464)
Employer Resources (175)
FDA (16511)
Job Trends (15233)
News (351745)
Policy (33257)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2638)
Accelerated approval (34)
Adcomms (24)
Allergies (146)
Alliances (50642)
ALS (174)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (318)
Approvals (16780)
Artificial intelligence (530)
Autoimmune disease (161)
Automation (42)
Bankruptcy (368)
Best Places to Work (11738)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (236)
Bladder cancer (160)
Brain cancer (58)
Breast cancer (649)
Cancer (4915)
Cardiovascular disease (408)
Career advice (1755)
Career pathing (36)
CAR-T (288)
CDC (46)
Celiac Disease (2)
Cell therapy (767)
Cervical cancer (37)
Clinical research (70445)
Collaboration (1763)
Company closure (4)
Compensation (1182)
Complete response letters (57)
COVID-19 (2762)
CRISPR (98)
C-suite (890)
Cystic fibrosis (145)
Data (6367)
Decentralized trials (2)
Denatured (27)
Depression (141)
Diabetes (509)
Diagnostics (6770)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (260)
Drug pricing (189)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90899)
Editorial (60)
Employer branding (21)
Employer resources (154)
Events (120987)
Executive appointments (1004)
FDA (19685)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1518)
Gene editing (206)
Generative AI (47)
Gene therapy (620)
GLP-1 (975)
Government (4740)
Grass and pollen (6)
Guidances (384)
Healthcare (19082)
HIV (63)
Huntington's disease (47)
IgA nephropathy (84)
Immunology and inflammation (258)
Immuno-oncology (63)
Indications (119)
Infectious disease (3040)
Inflammatory bowel disease (196)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (258)
Interviews (320)
IPO (16797)
IRA (50)
Job creations (3837)
Job search strategy (1470)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (559)
Leadership (33)
Legal (8116)
Liver cancer (91)
Longevity (16)
Lung cancer (662)
Lymphoma (385)
Machine learning (43)
Management (59)
Manufacturing (823)
MASH (164)
Medical device (13867)
Medtech (13923)
Mergers & acquisitions (20232)
Metabolic disorders (1286)
Multiple sclerosis (165)
NASH (16)
Neurodegenerative disease (325)
Neuropsychiatric disorders (90)
Neuroscience (2963)
Neurotech (1)
NextGen: Class of 2026 (6651)
Non-profit (4594)
Now hiring (68)
Obesity (603)
Opinion (277)
Ovarian cancer (167)
Pain (201)
Pancreatic cancer (235)
Parkinson's disease (288)
Partnered (33)
Patents (513)
Patient recruitment (503)
Peanut (58)
People (60373)
Pharmaceutical (77)
Pharmacy benefit managers (29)
Phase 1 (22053)
Phase 2 (31046)
Phase 3 (22984)
Pipeline (5471)
Policy (290)
Postmarket research (2579)
Preclinical (9392)
Press Release (71)
Prostate cancer (242)
Psychedelics (48)
Radiopharmaceuticals (287)
Rare diseases (865)
Real estate (6188)
Recruiting (72)
Regulatory (24878)
Reports (53)
Research institute (2451)
Resumes & cover letters (358)
Rett syndrome (27)
RNA editing (16)
RSV (82)
Schizophrenia (150)
Series A (251)
Series B (199)
Service/supplier (11)
Sickle cell disease (102)
Special edition (23)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3751)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (87)
The Weekly (57)
Vaccines (1031)
Venture capital (93)
Weight loss (386)
Women's health (95)
Worklife (19)
Date
Last 7 days (578)
Last 30 days (2239)
Last 365 days (30231)
2026 (4049)
2025 (30688)
2024 (35750)
2023 (40514)
2022 (51749)
2021 (56241)
2020 (54654)
2019 (47143)
2018 (35539)
2017 (32663)
2016 (32226)
2015 (38212)
2014 (32010)
2013 (27045)
2012 (29411)
2011 (30024)
2010 (28150)
Location
Africa (776)
Alabama (84)
Alaska (7)
Arizona (315)
Arkansas (13)
Asia (40392)
Australia (6740)
California (11529)
Canada (3333)
China (1125)
Colorado (484)
Connecticut (490)
Delaware (343)
Europe (87994)
Florida (1713)
Georgia (365)
Hawaii (3)
Idaho (61)
Illinois (901)
India (69)
Indiana (530)
Iowa (23)
Japan (440)
Kansas (131)
Kentucky (41)
Louisiana (26)
Maine (72)
Maryland (1406)
Massachusetts (8374)
Michigan (330)
Minnesota (637)
Mississippi (5)
Missouri (130)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (81)
New Jersey (3055)
New Mexico (29)
New York (3041)
North Carolina (1504)
North Dakota (9)
Northern California (5648)
Ohio (339)
Oklahoma (21)
Oregon (41)
Pennsylvania (2324)
Puerto Rico (25)
Rhode Island (48)
South America (1160)
South Carolina (67)
South Dakota (1)
Southern California (4481)
Tennessee (178)
Texas (1772)
United States (41000)
Utah (347)
Vermont (1)
Virginia (268)
Washington D.C. (82)
Washington State (947)
West Virginia (4)
Wisconsin (113)
Wyoming (2)
736,509 Results for "massachusetts biotechnology council inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
October 24, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
February 3, 2026
·
5 min read
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
·
6 min read
Job Trends
21 Companies Miss Massachusetts Hiring Targets, Affecting Hundreds of Jobs
Nearly two dozen life sciences companies that were awarded Massachusetts tax incentives to create and retain about 1,000 combined jobs hit just 13% of that target in 2024. Ten awardees had reported layoffs last year, including Charles River Laboratories and Moderna.
November 13, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
October 24, 2025
·
4 min read
Press Releases
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
October 17, 2025
·
4 min read
Press Releases
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development - February 10, 2026
February 11, 2026
·
3 min read
Job Trends
9 Companies Hiring Now in Massachusetts
Looking for a biopharma job in Massachusetts? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
August 21, 2025
·
1 min read
·
Chantal Dresner
Press Releases
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026
December 23, 2025
·
3 min read
Press Releases
MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO
March 20, 2025
·
4 min read
1 of 73,651
Next
